Livsmed Inc (KOSDAQ:491000)

Livsmed Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	44,159	27,121	17,267	9,678
Revenue Growth (YoY)	155.74%	57.07%	78.42%	-
Cost of Revenue	18,061	12,575	7,788	4,201
Gross Profit	26,098	14,547	9,479	5,477
Selling, General & Admin	34,833	28,731	24,113	17,328
Research & Development	12,637	10,697	7,640	4,529
Amortization of Goodwill & Intangibles	282.31	233.31	179.03	139.14
Other Operating Expenses	662.83	634.04	818.29	434.95
Operating Expenses	48,992	41,051	33,390	22,567
Operating Income	-22,894	-26,504	-23,912	-17,090
Interest Expense	-8,613	-8,613	-7,387	-5,192
Interest & Investment Income	740.26	740.26	193.78	43.33
Currency Exchange Gain (Loss)	1,304	1,304	99.34	330.94
Other Non Operating Income (Expenses)	9,147	7,489	-26,015	-37,112
EBT Excluding Unusual Items	-20,316	-25,585	-57,021	-59,019
Gain (Loss) on Sale of Assets	-	-	0.99	-
Pretax Income	-20,316	-25,585	-57,021	-59,019
Net Income	-20,316	-25,585	-57,021	-59,019
Net Income to Common	-20,316	-25,585	-57,021	-59,019
Shares Outstanding (Basic)	21	17	14	13
Shares Outstanding (Diluted)	21	17	14	13
Shares Change (YoY)	47.30%	17.94%	10.39%	-
EPS (Basic)	-973.43	-1530.99	-4024.24	-4597.99
EPS (Diluted)	-973.43	-1530.99	-4024.24	-4597.99
Free Cash Flow	-40,622	-32,009	-27,020	-18,535
Free Cash Flow Per Share	-1946.35	-1915.40	-1906.97	-1443.98
Gross Margin	59.10%	53.64%	54.90%	56.59%
Operating Margin	-51.84%	-97.72%	-138.48%	-176.59%
Profit Margin	-46.01%	-94.34%	-330.23%	-609.85%
Free Cash Flow Margin	-91.99%	-118.02%	-156.49%	-191.52%
EBITDA	-20,518	-24,858	-22,877	-16,362
EBITDA Margin	-46.46%	-91.65%	-132.49%	-169.06%
D&A For EBITDA	2,376	1,647	1,035	728.17
EBIT	-22,894	-26,504	-23,912	-17,090
EBIT Margin	-51.84%	-97.72%	-138.48%	-176.59%
Advertising Expenses	-	1,665	1,169	1,319

Source: S&P Global Market Intelligence. Standard template. Financial Sources.